Science ❯ Biology

Cancer Research

Solid Tumors Cell Structure Genome Stability Targeted Therapies Tumor Genetics Drug Development Microscopy Myeloid Cancers Tumor Biology Cancer Antigens Tumor Microenvironment Targeted Therapy Veterinary Oncology Cancer Mechanisms Tumor Development Glioblastoma Immunology Research Ethics

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

The purchase brings a first-in-class MLLT1/3 protein degrader into Amgen’s oncology research.

Dana-Farber to Pay $15 Million to Resolve DOJ Claims Over Manipulated Data in NIH-Funded Studies

Tunable Algae-Based Basement Membrane Replicates and Extends Matrigel for Breast Cell Studies

David Baltimore, Nobel Laureate Who Discovered Reverse Transcriptase, Dies at 87

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

UZH Researchers Unveil Real-Time CRISPR Platform to Decode Cancer Cell Evolution